Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials

Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Variation in Renin-Angiotensin System and Salt-Sensitivity Genes and the Risk of Diabetes Mellitus Associated With the Use of Thiazide Diuretics

(2009) O. Bozkurt et al.   AMERICAN JOURNAL OF HYPERTENSION

Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension

(2009) Ming-Sheng Zhou et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study

(2009) T. Sawada et al.   EUROPEAN HEART JOURNAL

Comparative Effects of Telmisartan and Eprosartan on Insulin Sensitivity in the Treatment of Overweight Hypertensive Patients

(2009) R. Fogari et al.   HORMONE AND METABOLIC RESEARCH

Next generation multifunctional angiotensin receptor blockers

(2009) Theodore W Kurtz et al.   HYPERTENSION RESEARCH

Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats

(2009) Marina C Muñoz et al.   JOURNAL OF HYPERTENSION

Cardioprotective Mechanism of Telmisartan via PPAR- -eNOS Pathway in Dahl Salt-Sensitive Hypertensive Rats

(2008) N. Kobayashi et al.   AMERICAN JOURNAL OF HYPERTENSION

New Onset Diabetes During Antihypertensive Therapy

(2008) M. H. Alderman   AMERICAN JOURNAL OF HYPERTENSION

Adrenergic, Metabolic, and Reflex Abnormalities in Reverse and Extreme Dipper Hypertensives

(2008) Guido Grassi et al.   HYPERTENSION

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

(2008)   LANCET

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

(2008) Salim Yusuf et al.   NEW ENGLAND JOURNAL OF MEDICINE